Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Frederick G. Vogt, Ph.D. is recorded as CEO at Iovance Biotherapeutics, Inc. (IOVA). Frederick G. Vogt, Ph.D. has spoken on 3 earnings calls and 2 other investor events across 1 company, most recently for Iovance Biotherapeutics, Inc. on June 4, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2021-05-19–present
Recorded roles and call appearances connecting this person to public companies.
CEO
2021-05-19–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
